ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,799,000 | +39.7% | 91,800 | +1.9% | 0.94% | +5.7% |
| Q2 2021 | $11,307,000 | -7.5% | 90,100 | 0.0% | 0.89% | -16.0% |
| Q1 2021 | $12,219,000 | -1.7% | 90,100 | -7.3% | 1.06% | +8.8% |
| Q4 2020 | $12,436,000 | +33.1% | 97,200 | +17.1% | 0.97% | +27.3% |
| Q3 2020 | $9,340,000 | +50.8% | 83,000 | +27.7% | 0.76% | -4.4% |
| Q2 2020 | $6,192,000 | +658.8% | 65,000 | +170.8% | 0.80% | +128.6% |
| Q2 2016 | $816,000 | – | 24,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |